Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Ulrik Lassen"'
Autor:
Andrés Cervantes, Maria Martinez-Garcia, Florence Joly, Georgina Meneses-Lorente, Maurizio Ceppi, Joan Albanell, Christelle Levy, Christoph Schindler, Iria Gonzalez, Véronique Diéras, Francesca Michielin, Annie Moisan, Celine Adessi, Martin Weisser, Wolfgang Jacob, Andreas Schneeweiss, Jose A. Lopez-Martin, Tomas Racek, Ulrik Lassen, Javier Cortes, Ian James, Max Hasmann, Tjoung-Won Park-Simon, Anja Welt, Marcus May, Frederik Marmé, Juan Miguel Cejalvo
Publikováno v:
INVESTIGATIONAL NEW DRUGS
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Schneeweiss, A, Park-Simon, T W, Albanell, J, Lassen, U, Cortés, J, Dieras, V, May, M, Schindler, C, Marmé, F, Cejalvo, J M, Martinez-Garcia, M, Gonzalez, I, Lopez-Martin, J, Welt, A, Levy, C, Joly, F, Michielin, F, Jacob, W, Adessi, C, Moisan, A, Meneses-Lorente, G, Racek, T, James, I, Ceppi, M, Hasmann, M, Weisser, M & Cervantes, A 2018, ' Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer ', Investigational New Drugs, vol. 36, no. 5, pp. 848-859 . https://doi.org/10.1007/s10637-018-0562-4
Investigational New Drugs
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Schneeweiss, A, Park-Simon, T W, Albanell, J, Lassen, U, Cortés, J, Dieras, V, May, M, Schindler, C, Marmé, F, Cejalvo, J M, Martinez-Garcia, M, Gonzalez, I, Lopez-Martin, J, Welt, A, Levy, C, Joly, F, Michielin, F, Jacob, W, Adessi, C, Moisan, A, Meneses-Lorente, G, Racek, T, James, I, Ceppi, M, Hasmann, M, Weisser, M & Cervantes, A 2018, ' Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer ', Investigational New Drugs, vol. 36, no. 5, pp. 848-859 . https://doi.org/10.1007/s10637-018-0562-4
Investigational New Drugs
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Summary Purpose To investigate the safety and clinical activity of comprehensive human epidermal growth factor receptor (HER) family receptor inhibition using lumretuzumab (anti-HER3) and pertuzumab (anti-HER2) in combination with paclitaxel in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0126ade335d0c5340693a09cb65b79e
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2445
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2445